08.11.2014 Views

Here - American Geriatrics Society

Here - American Geriatrics Society

Here - American Geriatrics Society

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

P OSTER<br />

A BSTRACTS<br />

physicians. Implementation of strategies to improve recognition of<br />

cognitive impairment may improve care of these patients, particularly<br />

at the time of hospital discharge.<br />

D141<br />

Arizona Alzheimer’s Registry: Strategy and Outcomes.<br />

K. T. Saunders, 1 C. Holt, 2 J. B. Langbaum, 2 W. Chen, 2 N. High, 2<br />

C. Langlois, 2 M. Sabbagh, 3 P. N. Tariot. 2 1. College of Medicine,<br />

University of Arizona, Phoenix, AZ; 2. Banner Alzheimer’s Institute,<br />

Phoenix, AZ; 3. Banner Sun Health Research Institute, Sun City, AZ.<br />

Supported By: NIA ADCC P30 AG19610, State of Arizona<br />

Medical Student Training in Aging Research (MSTAR) Program<br />

Background: The Arizona Alzheimer’s Consortium (AAC) is a<br />

statewide Alzheimer’s disease (AD) research consortium funded by<br />

NIA and the state of Arizona. In 2007 the AAC created a screening<br />

and referral process for people interested in participating in AD related<br />

research, as well as a relational database called the Arizona<br />

Alzheimer’s Registry (AAR). The goals of the AAR were to increase<br />

awareness of AD research and accelerate enrollment into AAC clinical<br />

research projects. The AAR matched Registrants to AAC research<br />

according to interest, location, and eligibility.<br />

Methods: Enrollment was by open invitation to volunteers age<br />

50 and older. Registrants were recruited by community outreach,<br />

mass mailings, earned and paid media, and the Internet. Those interested<br />

received a welcome packet, consent, and questionnaire, which<br />

were reviewed by trained staff via telephone prior to brief cognitive<br />

screening. Evaluation of medical history, cognitive status, and interests<br />

resulted in the Registrant being referred to existing AAC studies<br />

or being held for future referral.<br />

Results: 2263 people contacted the AAR; all but 231 were given<br />

a welcome packet. 1257 consented and 1182 underwent an initial cognitive<br />

screening. Earned media was the most effective recruitment<br />

strategy. Participants had a mean age of 68.1 (SD 10.6), 97% were<br />

Caucasian, had 15.2 (SD 2.7) mean years of education, and 60% were<br />

female. 30% reported a family history of dementia, 20% reported a<br />

diagnosis of cognitive impairment or dementia, and 70% subjectively<br />

reported normal cognition. The initial telephone assessment revealed<br />

681 with no impairment, 269 with possible cognitive impairment, and<br />

234 with possible dementia. 301 were referred to AAC sites.<br />

Conclusion: The AAR exceeded its goals of increasing awareness,<br />

Registry recruitment and research referral. This model was well<br />

received by the community and served as a mechanism for volunteers<br />

to explore their own cognitive status while making a contribution to<br />

the scientific community. The established infrastructure and experiences<br />

gained from the AAR will serve as the prototype for the webbased<br />

Alzheimer’s Prevention Registry, a national registry focusing<br />

on AD prevention research.<br />

D142<br />

Prevalence of Disruptive Behaviors Among PACE Participants.<br />

K. Kwak, 1 M.Trahan, 2 M. McNabney. 2 1. Stony Brook University<br />

School of Medicine, Stony Brook, NY; 2. Division of Geriatric<br />

Medicine and Gerontology, Johns Hopkins University, Baltimore, MD.<br />

Supported By: Johns Hopkins University; MSTAR Program<br />

Background: Disruptive behaviors occur in approximately 63%<br />

of adult day center participants. The Program for the All-inclusive<br />

Care of the Elderly (PACE) is a capitated and comprehensive service<br />

delivery system for older adults. PACE participants attend an adult<br />

day center where all care is coordinated and provided in order for<br />

participants to continue living in the community. The rate of disruptive<br />

behaviors among a PACE population is unknown.<br />

Objective: To study the frequency and type of disruptive behaviors<br />

typically displayed among PACE participants.<br />

Methods: This study took place at one PACE location in Maryland.<br />

To measure disruptive behaviors in PACE participants, we used<br />

the Cohen-Mansfield Agitation Inventory-Community (CMAI-C),<br />

consisting of 36 agitation items.<br />

Results: One hundred forty-two PACE participants (79% female)<br />

were included in the study. Dementia was present in 67<br />

(47%) participants. Among all the participants attending the PACE<br />

day center, 35.9% (45% with dementia and 28% without dementia)<br />

displayed at least one disruptive behavior once a week. The<br />

most frequently rated disruptive behavior was verbally non-aggressive<br />

behaviors (e.g., constant, unwarranted requests for attention,<br />

restless).<br />

Conclusions: PACE dementia participants display less disruptive<br />

behavior than seniors attending traditional day centers and residents<br />

living in nursing homes. From a psychosocial perspective, these<br />

results suggest that PACE might be better equipped to meet the physical,<br />

emotion, or social needs of participants when compared to traditional<br />

models of care.<br />

D143<br />

Guideline quandary in VTE prophylaxis management in elective<br />

joint replacement.<br />

J. Prager. <strong>Geriatrics</strong>, Mount Sinai Hospital, New York, NY.<br />

Introduction:<br />

Managing VTE prophylaxis from an evidence based approach,<br />

guidelines have been created from within both the <strong>American</strong> College<br />

of Chest Physicians (ACCP) and the <strong>American</strong> Academy of Orthopedic<br />

Surgeons (AAOS). Elective joint replacement epitomizes multidisciplinary<br />

care between orthopedics and internists to manage VTE prophylaxis<br />

concurrently while following conflicting recommendations.<br />

Case:<br />

An 85 year old female with a history of osteoarthritis presented<br />

to a tertiary care center for a scheduled left total hip arthroplasty for<br />

worsening symptoms of osteoarthritis. Patient was admitted to the orthopedic<br />

service. Post-operative day 0, patient was started on aspirin<br />

325mg BID for 35 days for VTE prophylaxis. On post-operative day<br />

9, patient’s hemoglobin had steadily decreased to 8.3 g/dl from a<br />

baseline of 12.7 g/dl. Patient was transfused 1 unit of packed red<br />

blood cells. Patient was discharged home with instructions to follow<br />

up with primary physician. Prior to patient’s appointment, patient<br />

called the primary physician’s office on a Saturday reaching the on<br />

call provider describing asymmetric leg swelling of post-operative<br />

leg. The on-call physician recommended for the patient to go to emergency<br />

room for evaluation for VTE, which was negative on ultrasound.<br />

Discussion:<br />

The ACCP recently updated VTE prophylaxis in 2008 categorizing<br />

elective joint replacement as a high risk procedure necessitating<br />

low molecular weight heparin i.e. enoxaparin, fondaparinux, or warfarin<br />

with an INR goal of 2.5. ACCP recommends against aspirin as<br />

VTE prophylaxis for elective joint replacement. Orthopedic concerns<br />

rest heavily on the underestimation of bleeding complications with<br />

evidence showing a 9% bleeding risk with 10 day course of ACCP<br />

recommended VTE prophylaxis coupled with 4.7% readmission rate<br />

in a study of 290 patients. AAOS recommendations are founded on<br />

evaluating patient’s risk of VTE combined with risk of bleeding. Aspirin<br />

remains as a treatment despite randomized controlled trials<br />

demonstrating superiority of low molecular weight heparin in secondary<br />

outcomes. Who should manage VTE prophylaxis? The longstanding<br />

internist or the current orthopedic surgeon? With the advent<br />

of newer agents i.e. rivaroxaban, the interest of patient safety is paramount<br />

to arrive at a unifying management protocol to decrease VTE<br />

post elective joint replacement while minimizing peri-operative<br />

bleeding.<br />

AGS 2012 ANNUAL MEETING<br />

S235

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!